home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
 
register for news alert 
 
 

news archive genetic news - December 1, 2005

  
  December 1, 2005
your information resource in human molecular genetics
  
     
- Cardiovascular safety determines the direction of PPAR agonist R&D
The two peroxisome proliferator-activated receptor (PPAR) gamma agonists pioglitazone and rosiglitazone approved for treatment of type 2 diabetes achieved combined 2004 global sales of US$ 3.96 bln

Generated by News Editor 2.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2024 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.